Skip to main content

Table 2 The strength of epidemiologic evidence of 22 meta-analyses of observational studies that affect the risk of NAFLD

From: Lifestyle as well as metabolic syndrome and non-alcoholic fatty liver disease: an umbrella review of evidence from observational studies and randomized controlled trials

Exposure

Measure

Reference

Precision of the estimate

Consistency of results

No evidence of small-study effects

Grade

>1000 disease cases

P < 0.001

I2 < 50% and Cochran Q test P > .10

P > 0.1

15 factors that increased the risk of NAFLD

 Smoking

NAFLD

Rezayat2017

Yes

No

Yes

Yes

Low

 Passive smoking

NAFLD

Rezayat2017

No

No

No

Yes

Low

 Former smoking

NAFLD

Rezayat2017

No

No

Yes

Yes

Low

 Soft drinks

NAFLD

He2020

Yes

Yes

Yes

No

Moderate

 sugar sweetened beverages

NAFLD

Asgar-Taee2018

Yes

No

Yes

Yes

Low

 Sugar-Sweetened Soda

NAFLD

Wijarnpreecha2015

Yes

Yes

Yes

Yes

High

 Hypercaloric fructose diet

IHLC

Chung2014

No

Yes

Yes

Yes

Moderate

 Red meat

NAFLD

He2020

Yes

No

No

No

Low

 Short sleep

NAFLD

Wijarnpreecha2016

Yes

No

Yes

Yes

Low

 Obesity

NAFLD

Li2016

Yes

Yes

No

Yes

Moderate

 Per 1-unit increase in WC

NAFLD

Pang2015

Yes

Yes

No

Yes

Moderate

 Per 1-unit increase in BMI

NAFLD

Pang2015

Yes

Yes

No

Yes

Moderate

 WHR

NAFLD

Pang2015

No

No

No

Yes

Low

 Hyperuricemia

NAFLD

Darmawan2017

Yes

Yes

No

Yes

Moderate

 Hyperuricemia

NAS

Jaruvongvanich2017

No

Yes

Yes

Yes

Moderate

7 factors that decreased the risk of NAFLD

 Modest alcohol

NAFLD

Sookoian2014

Yes

Yes

No

Yes

Moderate

 Modest alcohol

NASH

Sookoian2014

No

Yes

Yes

Yes

Moderate

 Coffee

NAFLD

Chen2018

Yes

Yes

No

Yes

Moderate

 Coffee

Liver fibrosis

Wijarnpreecha2017

No

Yes

No

No

Low

 Green tea

Liver steatosis

Yin2015

No

No

No

Yes

Low

 Nut

NAFLD

He2020

Yes

No

Yes

Yes

Low

 Weight loss

NASH

Koutoukidis2019

No

No

Yes

No

Low

  1. WHR Waist-tohip ratio, NAFLD Nonalcoholic fatty liver disease, HCL Intrahepatocellular lipids, Omega-3 PUFAs, WC Waist-tohip ratio, BMI Body mass index, NAS Non-alcoholic activity score, NASH Non-alcoholic steatohepatitis; omega-3 polyunsaturated fatty acids
  2. NOTE. The strength of epidemiologic evidence was rated as follows:
  3. High, if all criteria were satisfied: precision of the estimate (P < .001 and > 1000 disease cases), consistency of results (I2 < 50% and Cochran Q test P > .10), and no evidence of smallstudy effects (P > .10)
  4. Moderate, if a maximum of 1 criterion was not satisfied and a P < .001 was found
  5. Low, in other cases (P < .05)